ICON reports fourth quarter 2011 revenue of $243m, up 5% year on year, and EPS of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (ISIN:IE0005711209) Read more about ICON reports fourth quarter 2011 revenue of $243m, up 5% year on year, and EPS of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (ISIN:IE0005711209)
ICON Completes Acquisition of BeijingWits Medical Consulting Ltd Read more about ICON Completes Acquisition of BeijingWits Medical Consulting Ltd
ICON Selected by Shire plc's Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services Read more about ICON Selected by Shire plc's Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services
ICON Announces Dr. Anthony Murphy To Retire From Board of Directors Read more about ICON Announces Dr. Anthony Murphy To Retire From Board of Directors
ICON Acquires BeijingWits Medical Consulting Ltd Read more about ICON Acquires BeijingWits Medical Consulting Ltd
ICON plc: Commencement of Share Repurchase Programme Read more about ICON plc: Commencement of Share Repurchase Programme
ICON Names New Global Head of Clinical Research Services Read more about ICON Names New Global Head of Clinical Research Services
ICON Reports Q3 revenue growth of 7% to $241 million and net new business of $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209) Read more about ICON Reports Q3 revenue growth of 7% to $241 million and net new business of $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
ICON Announces Peter Gray To Retire As CEO Read more about ICON Announces Peter Gray To Retire As CEO
